Associate Professor of Pathology and Cell Biology Columbia University Irving Medical Center New York, New York, United States
This session will describe the challenges in clinical implementation of cancer whole exome sequencing, lessons learned, and clinical utility and utilization. After attending this session, attendees will be able to: 1. Describe challenges in clinical implementation of cancer whole exome sequencing. 2. Identify and assess clinical applications of this assay.
